Nadezhda Vladimirovna Palkina

Nadezhda Vladimirovna Palkina

Auto-generated profile, based on publicly available information

Nadezhda Vladimirovna Palkina

Pathophysiology Department, Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russian Federation

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in International Journal of Experimental Pathology
Verified
Journal Article
Closed access
PDF file
MAMariya B. Aksenenko
Mariya B. Aksenenko
NPNadezhda V. Palkina
Nadezhda V. Palkina
OSOlga N. Sergeeva
Olga N. Sergeeva
ESEkaterina Sergeeva
Ekaterina Sergeeva
AKAndrey K. Kirichenko
Andrey K. Kirichenko
TRTatyana Ruksha
Tatyana Ruksha

5 June 2025 in Exploration of Targeted Anti-tumor Therapy
Verified
Journal Article
Open access
PDF file
TRTatyana Ruksha
Tatyana Ruksha
NPNadezhda Palkina
Nadezhda Palkina
Transforming growth factor-β (TGF-β) is a multifunctional molecule with a dual role in carcinogenesis. Recent studies have demonstrated its various effects on cancer-related processes. However, the identification of TGF-β and TGF-β signaling pathway regulators in extracellular vesicles (EVs) appears promising for targeting them to control cancer progression associated with drug resistance. Exosomal TGF-β has been shown to be implicated in cancer cell phenotypic plasticity, a dynamic feature of cancer cells, and an evasive process hampering treatment efficacy. Additionally, EVs can influence the metastatic cascade through mechanisms, including their effects on the immune system and their binding to extracellular matrix (ECM) proteins. These processes collaborate to provide a supportive microenvironment for the development and growth of metastatic tumors. A deeper understanding of the mechanisms by which EVs facilitate TGF-β-mediated intercellular communication may have practical implications for better controlling oncological disorders and providing new methods for cancer diagnostics and treatment, including approaches targeting EVs.

1 January 2019 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
MAMariya Aksenenko
Mariya Aksenenko
NPNadezhda Palkina
Nadezhda Palkina
AKAnna Komina
Anna Komina
TRTatyana Ruksha
Tatyana Ruksha
Aksenenko M, et al. Ann Dermatol. 2019 Apr;31(2):256-259. https://doi.org/10.5021/ad.2019.31.2.256

20 May 2024 in Vestnik dermatologii i venerologii
Verified
Journal Article
Open access
PDF file
NPNadezhda Vladimirovna Palkina
Nadezhda Vladimirovna Palkina
RZRevaz D. Zenaishvili
Revaz D. Zenaishvili
TRTatyana Ruksha
Tatyana Ruksha
Exosomes are microvesicles secreted by different cells that have the specificity and ability to transfer their cargo, including various regulatory molecules, to other cells. Exosomes cargo analysis considered to be a promising approach for diagnostics and therapeutic agents delivery into cells. Molecules derived from exosome cargo supposed to be plausible diagnostics criteria. This review provides up-to-date information on the exosomes origin and composition followed by a description of their diagnostic potential. New data summarized on the possibilities of exosomes application for the treatment of chronic immune-mediated cutaneous disorders, alopecia and cutaneous wound healing.

29 June 2022 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
ELE. Z. Lapkina
E. Z. Lapkina
NPN. V. Palkinа
N. V. Palkinа
AAAnton Averchuk
Anton Averchuk
AEA. R. Esimbekova
A. R. Esimbekova
TRTatyana Ruksha
Tatyana Ruksha
Objective. To evaluate anti-tumor, toxic effect of miR-204-5p mimic applicaton on melanoma B-16-bearing mice followed by miR-204-5p target gene expression estimation in melanoma tumor and distant organs. Material and Methods. C57Bl/6 melanoma B-16-bearing mice were used. The animals of the experimental group were intraperitoneally injected with a 5 nM miR-204-5p miRNA simulator (mimic) on the 8th, 10th, and 12th days after melanoma B-16 cell transplantation. Based on the results of bioinformatic analysis, miR-204-5p target genes BCL2 and SIRT1 expression levels were determined by quantitative real-time PCR. The toxic effect of miR-204-5p mimic was estimated by the evaluation of body weight, mass of the internal organs, and motor activity. Results. On the 13-14th days of the experiment, the motor activity of animals in the control groups decreased signifcantly compared to the group of animals treated by miR-204-5p. Target gene BCL2 showed increased expression in the lungs and kidneys and SIRT1 levels were increased in the lungs of miR-204-5p mimic treated animals (p˂0.05). Tumor mass tended to decrease in the animals treated by miR-204-5p mimic. Conclusion. Modulation of the level of miR-204-5p microRNA led to changes in the expression of SIRT1 and BCL2 in the lungs of animals, and changes in the expression of BCL2in the kidneys. MiR-204-5p mimic application did not have toxic effect on animals treated. Further studies are necessary to clarify miR-204-5p implication in melanoma cell proliferation regulation as well as it’s biodistibution in the tumor tissue.

30 June 2019 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
SLS. N. Lavrentiev
S. N. Lavrentiev
MAM. B. Aksenenko
M. B. Aksenenko
AAAnton Averchuk
Anton Averchuk
AKA. V. Komina
A. V. Komina
NPN. V. Palkina
N. V. Palkina
TRTatyana Ruksha
Tatyana Ruksha
Various types of tissues was analyzed, and the algorithm for summing neutron and photon doses in neutronMiRNA s are involved in the regulation of numerous critical biological processes, including cell proliferation, differentiation, migration and invasion. They function as oncogenes or tumor suppressors according to the nature of the target. It has been previously determined that miR-204-5p miRNA is characterized by the increased level in melanoma. The aim of this study was to determine the effects of changes in the level of microRNA expression when dacarbazine was exposed to melanoma cells in vitro and synthetic miR-204-5p in vivo. The expression levels of miR-204-5p and miR-211 in melanoma cells were determined by real-time PCR. Antitumor effects in vivo were verified in assessing the growth dynamics of the tumor node. Toxic effects were assessed by animal behavior, fluid intake, feed, and ALT , AST , creatinine, urea levels. In the model of melanoma C57BL6, it was revealed that the introduction of the synthetic miR-204-5p did not cause significant changes in the investigated microRNA in tumor cells. At the same time, the antitumor effects of dacarbazine in melanoma cells in vitro led to an increase in the level of the investigated microRNA by more than 20 times. The results of the study indicated the possibility of compensating the level of miR-204-5p under the influence of cytostatic therapy. Taking into account the previously revealed miR-204-5p inhibitory effect on the proliferation of melanoma cells, we can assume that this miRNA can play a role in maintaining the dermal state of tumor cells. Further studies are required to understand the metastasis development and predict the response to antitumor therapy for melanoma.